Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Development of the Lymphatic System01:15

Development of the Lymphatic System

2.6K
The development of lymphatic tissues and vessels in embryonic life begins around the fifth week. These structures originate from the mesoderm layer, with lymph sacs emerging from developing veins.
The first lymph sacs to form are the paired jugular lymph sacs located at the junction of the internal jugular and subclavian veins. From these sacs, lymphatic capillary plexuses extend to the thorax, upper limbs, neck, and head, eventually forming lymphatic vessels. Each jugular lymph sac maintains a...
2.6K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

4.0K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
4.0K
Integrins01:10

Integrins

6.1K
Animal and protozoan cells do not have cell walls to help maintain shape and provide structural stability. Instead, these eukaryotic cells secrete a sticky mass of carbohydrates and proteins into the spaces between adjacent cells. This network of proteins and molecules is called an extracellular matrix or ECM.
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
6.1K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

3.8K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
3.8K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

2.8K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.8K
Activation of Integrins01:15

Activation of Integrins

5.6K
Integrins bind ligands and transmit information from outside the cell to inside or vice-versa through an "outside-in signaling" or "inside-out signaling."
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
5.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nivolumab-Associated Cardiac Manifestation of Cutaneous T-Cell Lymphoma in a Patient With Concurrent Renal Cell Carcinoma.

Mayo Clinic proceedings. Innovations, quality & outcomes·2026
Same author

Reduction in Hepatic Phosphatidylcholine Biosynthesis Promotes MASH Through Copper Deficiency.

bioRxiv : the preprint server for biology·2026
Same author

Key Risks and Mitigation Strategies in AI-accelerated MRI.

Radiology·2026
Same author

A flexible and unified framework for single- and multi-outcome Mendelian randomization using summary statistics.

American journal of human genetics·2026
Same author

Risk factors for early-onset and late-onset dementia: a prospective cohort study.

The lancet. Healthy longevity·2026
Same author

Year in Review 2025: Noteworthy Literature in Cardiac Anesthesiology.

Seminars in cardiothoracic and vascular anesthesia·2026

Related Experiment Video

Updated: Apr 1, 2026

Isolation of Human Lymphatic Endothelial Cells by Multi-parameter Fluorescence-activated Cell Sorting
07:36

Isolation of Human Lymphatic Endothelial Cells by Multi-parameter Fluorescence-activated Cell Sorting

Published on: May 1, 2015

15.1K

Integrin Alpha-9 Mediates Lymphatic Valve Formation in Corneal Lymphangiogenesis.

Eda Altiok1, Tatiana Ecoiffier1, Roberto Sessa1

  • 1Vision Science Graduate Program, University of California, Berkeley, California, United States 2Center for Eye Disease and Development, Program in Vision Science, and School of Optometry, University of California, Berkeley, California, United States.

Investigative Ophthalmology & Visual Science
|October 3, 2015
PubMed
Summary

Integrin alpha-9 (Itga-9) is crucial for forming corneal lymphatic valves. Blocking Itga-9 reduces valve formation and impairs lymphatic endothelial cell functions, offering new therapeutic targets.

More Related Videos

Static Adhesion Assay for the Study of Integrin Activation in T Lymphocytes
09:14

Static Adhesion Assay for the Study of Integrin Activation in T Lymphocytes

Published on: June 13, 2014

16.9K
Blocking Lymph Flow by Suturing Afferent Lymphatic Vessels in Mice
05:59

Blocking Lymph Flow by Suturing Afferent Lymphatic Vessels in Mice

Published on: May 14, 2020

7.1K

Related Experiment Videos

Last Updated: Apr 1, 2026

Isolation of Human Lymphatic Endothelial Cells by Multi-parameter Fluorescence-activated Cell Sorting
07:36

Isolation of Human Lymphatic Endothelial Cells by Multi-parameter Fluorescence-activated Cell Sorting

Published on: May 1, 2015

15.1K
Static Adhesion Assay for the Study of Integrin Activation in T Lymphocytes
09:14

Static Adhesion Assay for the Study of Integrin Activation in T Lymphocytes

Published on: June 13, 2014

16.9K
Blocking Lymph Flow by Suturing Afferent Lymphatic Vessels in Mice
05:59

Blocking Lymph Flow by Suturing Afferent Lymphatic Vessels in Mice

Published on: May 14, 2020

7.1K

Area of Science:

  • Ophthalmology
  • Immunology
  • Cell Biology

Background:

  • Corneal lymphatic vessels develop integrin alpha-9 (Itga-9)-positive valves during inflammatory lymphangiogenesis.
  • Understanding the role of Itga-9 in this process is essential for therapeutic development.

Purpose of the Study:

  • To investigate the role of integrin alpha-9 (Itga-9) in corneal lymphatic valve formation in vivo.
  • To examine the effect of Itga-9 on lymphatic endothelial cell (LEC) functions in vitro.

Main Methods:

  • Utilized a murine suture placement model to assess Itga-9 blockade's effect on corneal lymphatic valve formation.
  • Employed immunofluorescent microscopy for whole-mount cornea analysis.
  • Investigated human LEC functions following Itga-9 gene knockdown using small interfering RNAs (siRNAs) in vitro.

Main Results:

  • In vivo Itga-9 blockade significantly decreased the number of lymphatic valves in inflamed corneas.
  • In vitro Itga-9 gene knockdown suppressed human LEC proliferation, adhesion, migration, and tube formation.

Conclusions:

  • Integrin alpha-9 (Itga-9) plays a critical role in corneal lymphatic valve formation.
  • The Itga-9 pathway presents potential therapeutic strategies for lymphatic-related diseases.